Crispr Therapeutics AG (CRSP)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
5,243,643,000
EV to revenue ratio (TTM)
346.45
EV to ebitda
14.16
Financial Performance
Revenue (TTM)
13,392,000
Gross profit (TTM)
-461,800,992
EBITDA
-513,174,016
Profitability
Operating margin (TTM)
-1,128.00%
Profit margin
0.00%
Return on assets (TTM)
-14.20%
Return on equity (TTM)
-26.10%
Per Share Metrics
Revenue per share (TTM)
0.14
EPS
-4.71
Diluted EPS (TTM)
-4.71
Book value
18.07
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
23.36
PEG ratio
-0.214
Price to sales ratio (TTM)
391.55
Price to book ratio (TTM)
3.087
Growth
Quarterly earnings growth (YoY)
1,041.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
5
Buy
8
Hold
9
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.76